CLINICAL AND PARACLINICAL CHARACTERISTICS OF  HYALINE MEMBRANE DISEASE IN PREMATURE NEONATES  AT THAI NGUYEN HOSPITAL A

Nguyễn Thị Hoa; Nguyễn Thành Trung; Lê Hải Yến; Dương Thị Phương

doi:10.34238/tnu-jst.6723

CLINICAL AND PARACLINICAL CHARACTERISTICS OF HYALINE MEMBRANE DISEASE IN PREMATURE NEONATES AT THAI NGUYEN HOSPITAL A

About this article

Received: 20/10/22 Revised: 04/11/22 Published: 24/11/22

Authors

1. Nguyen Thi Hoa , Thai Nguyen Medical College
2. Nguyen Thanh Trung, Thai Nguyen National Hospital
3. Le Hai Yen, Medical Center of Thai Nguyen City
4. Duong Thi Phuong, Thai Nguyen Medical College

Abstract

Hyaline membrane disease is also one of the leading causes of respiratory failure in infants, which, if not treated quickly and properly, can lead to death. This paper aims to describe the clinical and paraclinical characteristics of Hyaline membrane disease in premature neonates at Thai Nguyen hospital A in 2022. The study used a cross-sectional descriptive study design, collected information from 51 premature neonates diagnosed with Hyaline membrane disease at Thai Nguyen Hospital A from August 2021 to July 2022. The results showed that most of the children had a gestational age of less than 32 weeks (51.0%), the mean gestational age in boys (32.0±2.69) was higher than that of girls (30.4±1.4), weighing the average weight of children is 1527.25g. The most common clinical symptoms in pediatric patients were cyanosis (98%) and groaning (86.3%). The blood gas indexes are all below normal and 100% of children have grade 3 and grade 4 on Radiography. After 1 hour surfactant treatment, blood gas index, SpO₂ and FiO₂ were within normal limits. After at least 6 hours surfactant treatment, 13.7% of the children had X-ray grades 3 and none of the children had X-ray grades 4. Therefore, using surfactant in preterm infants with endothelial disease brought about a significant effect, blood gas index, SpO₂, FiO₂, chest X-ray were all improved.

Keywords

Hyaline membrane disease; Premature neonates; Surfactant; Thai Nguyen Hospital A; Pediatric department

Full Text:

PDF (Tiếng Việt)

References

[1] B. M. Birihane, W. A. Bayih, A. Y. Alemu, D. M. Belay, and A. Demis, "The burden of hyaline membrane disease, mortality and its determinant factors among preterm neonates admitted at Debre Tabor General Hospital, North Central Ethiopia: A retrospective follow up study," PLoS One, vol. 16, no. 3, 2021, Art. no. e0249365.

[2] J. Liu, N. Yang, and Y. Liu, "High-risk Factors of Respiratory Distress Syndrome in Term Neonates: A Retrospective Case-control Study," Balkan Med J, vol. 31, no. 1, pp. 64-68, 2018.

[3] M. J. Sankar, N. Gupta, K. Jain, R. Agarwal, and V. K. Paul, "Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review," Journal of Perinatology, vol. 36, pp. S36–S48, 2016.

[4] H. P. T. Nguyen, T. C. Tran, and N. T. Nguyen, "Assessment of the results of treatment Neoatal Acute Respiratory Disorder and some factors related," Vietnam Medical Journal, vol. 515, no. 1, pp. 82-89, 2022.

[5] L. T. T. Le and T. K. Huynh, "The clinical characteristics and the results of treatment for acute Respiratory Distress Syndrome in Preterm Infants at Can Tho Pediatrics Hospital," Cantho Journal of Medicine and Pharmacy, vol. 15, pp. 171-177, 2018.

[6] T. N. N. Le, D. T. T. Le, T. T. P. Tran, and X. M. Ngo, "Outcomes of Preterm infants 26-34 weks Gestation in Children Hospital 2," Ho Chi Minh City Journal of Medicine, vol. 20, no. 2, pp. 29-35, 2015.

[7] V. T. Vo, L. H. Nguyen, and M. T. Lam, "The result of Surfactant administration in Preterm Infantstreated or Respiratory Distress Syndrome in the Neonatal intensive care unit of Children's Hospital 2 from 01/6/2014 to 30/4/2015," Ho Chi Minh City Journal of Medicine, vol. 20, no. 1, pp. 58-62, 2016.

[8] D. T. Hoang, "Results of using surfactant to treat respiratory failure in preterm infants in Thai Nguyen," Master Thesis of Medicine, Thai Nguyen University of Medicine and Pharmacy, 2017.

[9] M. E. Avery and J. Mead, "Surface properties in relation to atelectasis and hyaline membrane disease," AMA J Dis Child, vol. 97, no. 5, pp. 517-523, 1959.

[10] T. T. Tran, "Evaluation of the results of treatment of endocarditis in preterm infants with Curosurf at Bac Ninh Obstetrics and Gynecology Hospital," Thesis level II of Medicine, Thai Nguyen University or Medicine and Pharmacy, 2018.

[11] N. T. Nguyen, "Research on causes, risk factors and outcomes of respiratory failure treatment in neonates at Pediatrics Department, Bach Mai Hospital," Doctor of Medicine Thesis, Vietnam Military Medical University, 2018.

[12] L. Wang et al., "Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome," Int J Clin Exp Med, vol. 8, no. 8, pp. 13783-13789, 2015.

mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:

EN-US;mso-bidi-language:AR-SA'>

DOI: https://doi.org/10.34238/tnu-jst.6723

Refbacks

There are currently no refbacks.



Remember me